138 related articles for article (PubMed ID: 10624566)
1. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition.
Osawa M; Swindells MB; Tanikawa J; Tanaka T; Mase T; Furuya T; Ikura M
J Mol Biol; 1998 Feb; 276(1):165-76. PubMed ID: 9514729
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
[TBL] [Abstract][Full Text] [Related]
4. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
5. Dynamic secondary structural changes in Ca²⁺-saturated calmodulin upon interaction with the antagonist, W-7.
Sasakura D; Nunomura W; Takakuwa Y
Biochem Biophys Res Commun; 2012 Jun; 423(2):360-5. PubMed ID: 22664109
[TBL] [Abstract][Full Text] [Related]
6. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin antagonists enhance calcium binding to calmodulin.
Inagaki M; Tanaka T; Hidaka H
Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the acrosome reaction of sea urchin spermatozoa by a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7).
Sano K
J Exp Zool; 1983 Jun; 226(3):471-3. PubMed ID: 6886669
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of calcium fluxes and calmodulin block activation of the p21-activated protein kinases in neutrophils.
Lian JP; Crossley L; Zhan Q; Huang R; Coffer P; Toker A; Robinson D; Badwey JA
J Immunol; 2001 Feb; 166(4):2643-50. PubMed ID: 11160327
[TBL] [Abstract][Full Text] [Related]
10. The binding of myristoylated N-terminal nonapeptide from neuro-specific protein CAP-23/NAP-22 to calmodulin does not induce the globular structure observed for the calmodulin-nonmyristylated peptide complex.
Hayashi N; Izumi Y; Titani K; Matsushima N
Protein Sci; 2000 Oct; 9(10):1905-13. PubMed ID: 11106163
[TBL] [Abstract][Full Text] [Related]
11. A fluorescence polarization-based assay for the identification and evaluation of calmodulin antagonists.
Arai T; Yatabe M; Furui M; Akatsuka H; Uehata M; Kamiyama T
Anal Biochem; 2010 Oct; 405(2):147-52. PubMed ID: 20599654
[TBL] [Abstract][Full Text] [Related]
12. N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide(W-7), a calmodulin antagonist, also inhibits phospholipid-sensitive calcium-dependent protein kinase.
Schatzman RC; Raynor RL; Kuo JF
Biochim Biophys Acta; 1983 Jan; 755(1):144-7. PubMed ID: 6297609
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), a calmodulin antagonist in arterial strips from rats and rabbits.
Asano M; Hidaka H
J Pharmacol Exp Ther; 1985 Aug; 234(2):476-84. PubMed ID: 4020681
[TBL] [Abstract][Full Text] [Related]
14. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride) (W-7) causes increases in intracellular free Ca2+ levels in bladder female transitional carcinoma (BFTC) cells.
Jan CR; Yu CC; Huang JK
Anticancer Res; 2000; 20(6B):4355-9. PubMed ID: 11205271
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
[TBL] [Abstract][Full Text] [Related]
16. Evidence for calmodulin inter-domain compaction in solution induced by W-7 binding.
Osawa M; Kuwamoto S; Izumi Y; Yap KL; Ikura M; Shibanuma T; Yokokura H; Hidaka H; Matsushima N
FEBS Lett; 1999 Jan; 442(2-3):173-7. PubMed ID: 9928996
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
Matsushima N; Hayashi N; Jinbo Y; Izumi Y
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
[TBL] [Abstract][Full Text] [Related]
18. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
Quinn JC; Johnson-Farley NN; Yoon J; Cowen DS
J Pharmacol Exp Ther; 2002 Nov; 303(2):746-52. PubMed ID: 12388661
[TBL] [Abstract][Full Text] [Related]
19. Complexes formed between calmodulin and the antagonists J-8 and TFP in solution.
Craven CJ; Whitehead B; Jones SK; Thulin E; Blackburn GM; Waltho JP
Biochemistry; 1996 Aug; 35(32):10287-99. PubMed ID: 8756684
[TBL] [Abstract][Full Text] [Related]
20. Myristoylation-regulated direct interaction between calcium-bound calmodulin and N-terminal region of pp60v-src.
Hayashi N; Nakagawa C; Ito Y; Takasaki A; Jinbo Y; Yamakawa Y; Titani K; Hashimoto K; Izumi Y; Matsushima N
J Mol Biol; 2004 Apr; 338(1):169-80. PubMed ID: 15050832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
